Cognitive function following dipeptidyl peptidase 4 inhibitors use in older adults with type 2 diabetes: A nationwide cohort study

Abstract

Background: Dipeptidyl peptidase 4 inhibitors (DPP‐4i) are widely used antidiabetic medications with reported neuroprotective potential beyond their glycemic control effects. Nonetheless, the association between DPP‐4i use and cognitive function is unclear.